scholarly journals Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge

2014 ◽  
pp. 129 ◽  
Author(s):  
Rami Doukky ◽  
Yasmeen Golzar
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Current Knowledge ◽  
The State ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease

Screening of High-risk Patients for Chronic Obstructive Pulmonary Disease in Primary Care: A Narrative Review (Preprint)

2020 ◽  
Author(s):  
Ponrathi Athilingam ◽  
Andrew Bugajski ◽  
Usha Menon
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Lung Function ◽  
Pulmonary Disease ◽  
Current Knowledge ◽  
Screening Tools ◽  
Chronic Obstructive ◽  
Early Screening ◽  
Obstructive Pulmonary Disease ◽  
Impaired Lung Function ◽  
Risk Patients

UNSTRUCTURED Chronic obstructive pulmonary disease (COPD) predominantly affects older adults, and claimed 3 million lives in 2016, making it the third leading cause of death worldwide. Over 35 million Americans aged 40 or older have lung function consistent with diagnosable COPD. COPD and cardiovascular disease (CVD) have a bidirectional relationship, in that one is a risk factor for developing the other. National and international consortiums recommend early screening of adults at risk of COPD, such as those with CVD. Recommended screening strategies include screening tools to assess symptoms, medical history, and handheld spirometry. Handheld spirometry has high diagnostic accuracy and if impaired lung function is indicated, these patients are referred for pulmonary function testing (PFT), the diagnostic gold standard for COPD. However, there is no clinical consensus for pulmonary screening in people with CVD. Current knowledge relating to the prevalence and incidence of CVD in people with COPD and the mechanisms that underlie their coexistence is key in combating the global burden of COPD.

Bronchodilator and anti-inflammatory therapy of chronic obstructive pulmonary disease from the position of interchangeability

2021 ◽  
Vol 31 (4) ◽  
pp. 518-529
Author(s):  
E. A. Orlova ◽  
I. P. Dorfman ◽  
M. A. Orlov ◽  
A. K. Andreeva ◽  
M. A. Abdullaev
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Generic Drugs ◽  
The State ◽  
Chronic Obstructive ◽  
Anticholinergic Drugs ◽  
Adherence To Treatment ◽  
Obstructive Pulmonary Disease ◽  
State Register ◽  
Anti Inflammatory

The choice of drugs used to treat patients with chronic obstructive pulmonary disease (COPD) (inhaled β-agonists, M-anticholinergic drugs, inhaled corticosteroids (ICS)) in view of their interchangeability is reviewed in this article. This aspect is especially important for clinicians when choosing an effective and safe treatment for COPD and for increasing patient adherence to treatment.The aim of this study was to assess the ratio of the number of reference (original), interchangeable, and generic drugs used in COPD.Methods. In accordance with the Russian clinical guidelines 2018 and GOLD 2019, modern drugs for the treatment of COPD with bronchodilator and anti-inflammatory activity were selected. All trade names of the corresponding drugs for each international non-proprietary name (INN) In the State Register of Medicines website were considered. The information on the availability of reference (original) drugs and the corresponding interchangeable products, as well as their presence in the List of vital and essential drugs was analyzed.Results. A large number of generic prodcuts are registered in the State Register of Medicines, and only a few of them are interchangeable with the corresponding reference (original) drug.Conclusion. The analysis will help widen the doctors’ choice of interchangeable drugs in treatment of COPD with an equivalent effect and safety of reference drugs, as well as to increase the patients’ adherence to treatment.

scholarly journals CARDIORENAL INTERRELATIONSHIPS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

2018 ◽  
Vol 1 (68) ◽  
pp. 29-33
Author(s):  
Ираида Меньшикова ◽  
Iraida Men'shikova ◽  
Юлия Квасникова ◽  
Yuliya Kvasnikova ◽  
Елена Магаляс ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Blood Flow ◽  
Left Ventricle ◽  
Right Ventricle ◽  
Renal Blood Flow ◽  
Pulmonary Disease ◽  
The State ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Vessel Resistance

The aim is to study the interrelationships between the state of pulmonary, intracardiac hemodynamics and renal blood flow in patients with chronic obstructive pulmonary disease (COPD) complicated with the chronic cor pulmonale (CCP). 75 patients with COPD complicated with compensated CCP who had the study of pulmonary, intracardiac and renal hemodynamics with the method of ultrasound duplex scanning were examined. The patients were divided into 2 groups: the 1st group included 45 patients with COPD with pulmonary hypertension (PH) without clinical signs of right ventricle insufficiency; the 2nd group included 30 patients with COPD and PH complicated with right ventricle insufficiency. It was found out that the patients with COPD alongside with the progression of the disease and development of the heart insufficiency had an increase of renal vessel resistance (p<0.01) and a decrease of the velocity of renal blood flow (p<0.001). In the first group of patients there was found a consistent correlation between the increase of the vessel resistance in renal arteries and growth of general peripheral vessel resistance (p<0.001), of systolic pressure in the pulmonary artery (p<0.001) and diastolic dysfunction of the left ventricle (LV) (p<0.001), suggested the influence of these predictors on the velocity of the arterial blood flow in kidneys. In the 2nd group there was registered a strong correlation between the decrease of ejection fraction (EF) of LV and the increase of pulsation and resistive indices of arcuate arteries (r=0.69; p<0.01 and r=0.71; p<0.01, respectively), as well as the increase of end-diastolic volume, end-systolic volume of LV and speed parameters of the renal blood flow at all levels (r=0.67; p<0.01). The study of the relationship between the parameters of hemodynamics of the right ventricle (RV) and the state of the renal blood flow revealed a consistent correlation between the decrease of EF of RV and the decrease of diastolic rate at all levels of renal arteries (p<0.001), the increase of resistive (p<0.01) and pulsation indices (p<0.01) of the arterial system of kidneys. These correlations reflect a negative influence of both a left ventricle and right ventricle insufficiency on the state of the renal blood flow.

Sign in / Sign up

Export Citation Format

Share Document